Important COVID-19 information: All event teams are taken action to ensure health and safety of all delegates. This will result in postponement, change to e-seminar or other changes. Please visit the event pages to get the latest information. If you follow the event you will be updated on the latest changes. Please stay safe in these difficult times.

Past event: Aggregate Spend and Open Payments Conference

Enhance reporting processes to ensure compliant, transparent and ethical interactions between life science manufacturers and healthcare professionals

The demand for transparency when looking at the relationship between life science manufacturers and health care providers is at an all-time high. Recent updates to the Physicians Payments Sunshine Act will increase the scope of responsibilities for manufacturers and HCPs alike. The current landscape surrounding aggregate spend and the open payments system also involves the discussion of conflicts of interest, ethical interactions, and federal enforcement.

Interactions with HCPs can provide tremendous value to life science manufacturers but also presents risks for provider disputes or legal violations. Enforcement in the industry is constantly evolving on state, federal and global levels. With differences in reporting requirements, it is up to manufacturers to manage risk, maintain transparency and ensure compliance at all times, which can be extremely difficult. We are proud to bring you the 10th Aggregate Spend and Open Payments Conference. Over the past nine years, we have had the privilege of educating over 223 organizations and will continue to provide thought-provoking sessions, interactive panels, and spotlight sessions this year.

Top Five Reasons to Attend

  1. Explore Sunshine Act and Open Payments System updates with the Centers for Medicare and Medicaid Services Director, Robin Usi
  2. Interact with DOJ representatives and in-house counsel members to discuss the current enforcement landscape
  3. Gain insight from 20+ expert speakers from various backgrounds, including speakers from Boehringer Ingelheim, Daiichi Sankyo, Bayer, Otsuka, Chiesi, Shinogi and more
  4. Discuss the best practices for identifying, collecting, and analyzing the data required for open payments reporting
  5. Investigate emerging trends and high-risk areas including federal, state and global policies, privacy implications, price transparency, and ethical considerations

Who Should Attend

This conference is designed for representatives from pharmaceutical, biotechnology, and medical device companies and advocacy groups with responsibilities in the following areas:
  • Aggregate Spend
  • Compliance
  • Transparency
  • Corporate/Regulatory/Risk Compliance and Ethics
  • Government/Federal/State Reporting
  • Legal and Regulatory Affairs
  • Transparency Spend Reporting
  • Business Analysis and Development
  • Finance and Accounting
  • Financial Management Analytics
  • Data Management
  • Professional Affairs
  • Sales and Marketing
  • Commercial Operations
  • Clinical Operations/Disclosure
  • Medical Affairs
  • Contract Administrators
  • Grant Writing
  • Internal and External Training
  • Engagement
This conference is also of interest to:
  • Sunshine Reporting Solution Providers
  • Data Management Solution Providers
  • Complaisance Solution Providers
  • Transparency Reporting Solution Providers


  • Marc Adler, Esq., President and Founder, GLOBAL COMPLIANCE STRATEGIES
  • Sergio Alegre, Vice President of Global Compliance, OSMOTICA PHARMACEUTICAL
  • Isha Arora, Compliance Consultant
  • Bernard Cooney, Assistant United States Attorney, District of New Jersey, U.S. DEPARTMENT OF JUSTICE
  • Charlene E. Davis, Esq., Associate Vice President and Head of Healthcare Compliance North America, SUN PHARMACEUTICAL INDUSTRIES
  • Nicodemo Fiorentino, Esq., Senior Manager, Compliance Operations and Transparency, SUN PHARMA
  • Daniel Font, CIIP-US, CIPM, Director, Compliance Investigations, Policy and Training, DAIICHI SANKYO
  • Bill Friedrich, Senior Manager, Compliance, HIKMA PHARMACEUTICALS
  • Melissa Kaschak, CPA, CFE, CISA, Compliance Operations, OLYMPUS
  • Kari K. Loeser, U.S. Healthcare Compliance Officer, RELYPSA
  • Joseph Mack, Senior Compliance Counsel, BAYER
  • Heather McCollum, J.D., MHA, CCEP-I, Director, Compliance, SHIONOGI
  • Natalia Morozkina, Compliance Manager, OTSUKA PHARMACEUTICAL COMPANIES
  • Sharon Muscato, Director, Transparency and Compliance Operations, ALEXION PHARMACEUTICALS
  • Bryan Stefanski, Compliance Director, SIEMENS HEALTHCARE
  • Bryan Stinehour, Product Manager, MEDISPEND
  • Thomas Sullivan, Editor/Publisher, POLICY AND MEDICINE
  • Sheea Sybblis, Senior Counsel, BOEHRINGER INGELHEIM
  • Robin Usi, Director, Division of Data and Informatics, Center for Program Integrity, CENTERS FOR MEDICARE & MEDICAID SERVICES
  • Amy Valiante Ross, Vice President, Contracts and Compliance, CHIESI USA
  • Donna White, Vice President, Contracts and Compliance, CHIESI USA

Please fill in your name and email to receive the Conference Agenda of this event.


The Inn at Penn, A Hilton Hotel
3600 Sansom Street, 19104
Philadelphia, PA, USA


The Inn at Penn, A Hilton Hotel
3600 Sansom Street
Philadelphia, PA 19104

Enjoy a refreshing and rewarding experience at The Inn at Penn, A Hilton Hotel in University City. This AAA Four Diamond hotel is located on the University of Pennsylvania campus. Stay at this hotel and be near famous attractions, museums, and the medical and business districts, and just 20 minutes from Philadelphia International Airport. An ideal base with a prime location to explore all Philadelphia has to offer.

To make reservations, please call 215-823-6240 and request the group rate for ExL's June Meetings. To make reservations online Click Here

The group rate is available until May 28, 2019. Please book your room early, as rooms available at this rate are limited.
Event details
Organizer : ExL
Event type : Conference
Reference : ASDE-20342